| extraocular skeletal muscle development | GO:0002074 | 1 | 1.000 | |
| menstrual cycle phase | GO:0022601 | 2 | 1.000 | |
| menstruation | GO:0042703 | 1 | 1.000 | |
| hard palate development | GO:0060022 | 1 | 1.000 | |
| cardiac cell fate determination | GO:0060913 | 3 | 1.000 | |
| neural crest cell development | GO:0014032 | 3 | 0.999 | |
| enteric nervous system development | GO:0048484 | 1 | 0.999 | |
| cranial nerve development | GO:0021545 | 4 | 0.996 | |
| trophectodermal cell differentiation | GO:0001829 | 3 | 0.990 | Mouse |
| soft palate development | GO:0060023 | 3 | 0.981 | |
| endochondral bone morphogenesis | GO:0060350 | 3 | 0.981 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 2 | 0.974 | |
| nerve development | GO:0021675 | 4 | 0.973 | |
| blastocyst formation | GO:0001825 | 3 | 0.964 | Mouse |
| tongue development | GO:0043586 | 1 | 0.962 | |
| nucleosome assembly | GO:0006334 | 50 | 0.960 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 23 | 0.941 | |
| epithelial tube branching involved in lung morphogenesis | GO:0060441 | 4 | 0.938 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.934 | |
| lymphangiogenesis | GO:0001946 | 7 | 0.932 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.929 | |
| endocrine system development | GO:0035270 | 26 | 0.926 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.920 | |
| endothelial cell migration | GO:0043542 | 86 | 0.918 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.915 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.911 | Mouse |
| equilibrioception | GO:0050957 | 6 | 0.906 | |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.897 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.889 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.884 | |
| cell fate determination | GO:0001709 | 3 | 0.874 | |
| positive regulation of peptidase activity | GO:0010952 | 88 | 0.868 | |
| neural crest cell migration | GO:0001755 | 2 | 0.860 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.852 | |
| pharynx development | GO:0060465 | 1 | 0.847 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.844 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.837 | |
| positive regulation of male gonad development | GO:2000020 | 3 | 0.827 | |
| somatic stem cell maintenance | GO:0035019 | 4 | 0.817 | |
| positive regulation of endopeptidase activity | GO:0010950 | 84 | 0.815 | |
| epithelial cell migration | GO:0010631 | 119 | 0.814 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.809 | |
| regulation of cell migration | GO:0030334 | 289 | 0.803 | |
| negative regulation of epithelial to mesenchymal transition | GO:0010719 | 14 | 0.797 | |
| chromatin assembly or disassembly | GO:0006333 | 78 | 0.796 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.793 | |
| regulation of cell motility | GO:2000145 | 299 | 0.789 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.784 | |
| negative regulation of stem cell differentiation | GO:2000737 | 22 | 0.773 | |
| blastocyst development | GO:0001824 | 3 | 0.765 | Mouse |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.765 | |
| pancreas development | GO:0031016 | 19 | 0.760 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.752 | |
| thymus development | GO:0048538 | 3 | 0.748 | |
| male genitalia development | GO:0030539 | 1 | 0.745 | |
| regulation of locomotion | GO:0040012 | 329 | 0.744 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.739 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.734 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.712 | |
| mesenchymal cell differentiation | GO:0048762 | 52 | 0.706 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.702 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.702 | |
| digestive system development | GO:0055123 | 75 | 0.700 | |
| detection of mechanical stimulus involved in sensory perception | GO:0050974 | 1 | 0.690 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 61 | 0.687 | Human |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.683 | |
| negative regulation of glial cell proliferation | GO:0060253 | 2 | 0.682 | |
| protein ubiquitination | GO:0016567 | 314 | 0.678 | |
| autonomic nervous system development | GO:0048483 | 1 | 0.667 | |
| negative regulation of gliogenesis | GO:0014014 | 3 | 0.665 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.660 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.656 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 37 | 0.638 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.638 | |
| regulation of body fluid levels | GO:0050878 | 99 | 0.638 | |
| lymph vessel development | GO:0001945 | 9 | 0.628 | |
| chromatin assembly | GO:0031497 | 61 | 0.622 | |
| cardiac cell fate commitment | GO:0060911 | 7 | 0.619 | |
| embryonic placenta development | GO:0001892 | 1 | 0.612 | |
| thyroid gland development | GO:0030878 | 5 | 0.609 | |
| response to lipid | GO:0033993 | 206 | 0.598 | Mouse |
| stem cell development | GO:0048864 | 69 | 0.595 | |
| positive regulation of mesenchymal stem cell differentiation | GO:2000741 | 4 | 0.586 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.573 | |
| negative regulation of transport | GO:0051051 | 176 | 0.569 | Mouse |
| cell development | GO:0048468 | 328 | 0.569 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.551 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.549 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.546 | |
| female gonad development | GO:0008585 | 10 | 0.540 | |
| response to wounding | GO:0009611 | 168 | 0.527 | |
| bone morphogenesis | GO:0060349 | 10 | 0.522 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.520 | |
| neuron fate commitment | GO:0048663 | 2 | 0.511 | |
| notch signaling pathway | GO:0007219 | 31 | 0.511 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.504 | |
| endoderm formation | GO:0001706 | 33 | 0.502 | |
| regulation of protein transport | GO:0051223 | 213 | 0.498 | |
| osteoblast differentiation | GO:0001649 | 92 | 0.497 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.496 | |
| nervous system development | GO:0007399 | 293 | 0.495 | |
| regulation of intracellular estrogen receptor signaling pathway | GO:0033146 | 13 | 0.494 | |
| stem cell differentiation | GO:0048863 | 93 | 0.492 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 2 | 0.490 | |
| protein acylation | GO:0043543 | 138 | 0.490 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.489 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.488 | |
| mesenchyme development | GO:0060485 | 59 | 0.487 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.473 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.470 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.468 | |
| angiogenesis | GO:0001525 | 147 | 0.468 | |
| chromatin organization | GO:0006325 | 351 | 0.456 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.444 | |
| regeneration | GO:0031099 | 4 | 0.442 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.441 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.441 | |
| chromatin modification | GO:0016568 | 298 | 0.438 | |
| regulation of blood coagulation | GO:0030193 | 42 | 0.433 | |
| positive regulation of epithelial cell migration | GO:0010634 | 55 | 0.433 | |
| hemostasis | GO:0007599 | 76 | 0.429 | |
| regulation of cell cycle arrest | GO:0071156 | 36 | 0.425 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.417 | |
| regulation of intracellular steroid hormone receptor signaling pathway | GO:0033143 | 32 | 0.412 | |
| regulation of epithelial cell migration | GO:0010632 | 93 | 0.412 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.411 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.410 | |
| signal transduction in response to dna damage | GO:0042770 | 57 | 0.404 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.395 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.391 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.388 | |
| cardiocyte differentiation | GO:0035051 | 23 | 0.386 | |
| coagulation | GO:0050817 | 78 | 0.385 | |
| lymph vessel morphogenesis | GO:0036303 | 7 | 0.376 | |
| blood vessel development | GO:0001568 | 172 | 0.373 | |
| protein acetylation | GO:0006473 | 116 | 0.370 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.368 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.361 | |
| brain morphogenesis | GO:0048854 | 1 | 0.361 | |
| regulation of glial cell proliferation | GO:0060251 | 4 | 0.355 | |
| cell fate commitment involved in formation of primary germ layer | GO:0060795 | 6 | 0.351 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.346 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.346 | |
| neuron differentiation | GO:0030182 | 138 | 0.344 | |
| positive regulation of stem cell differentiation | GO:2000738 | 29 | 0.343 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.342 | |
| blood coagulation | GO:0007596 | 76 | 0.337 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 48 | 0.334 | |
| epithelium development | GO:0060429 | 227 | 0.330 | |
| gliogenesis | GO:0042063 | 21 | 0.329 | |
| negative regulation of sodium ion transmembrane transporter activity | GO:2000650 | 2 | 0.329 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 55 | 0.327 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.327 | |
| melanocyte differentiation | GO:0030318 | 2 | 0.325 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.325 | |
| bone development | GO:0060348 | 26 | 0.319 | |
| response to estrogen | GO:0043627 | 47 | 0.318 | |
| cell cycle checkpoint | GO:0000075 | 117 | 0.317 | |
| endoderm development | GO:0007492 | 33 | 0.316 | |
| gastrulation | GO:0007369 | 51 | 0.315 | |
| wound healing | GO:0042060 | 115 | 0.315 | |
| second messenger mediated signaling | GO:0019932 | 78 | 0.312 | |
| male sex differentiation | GO:0046661 | 25 | 0.311 | |
| immune system development | GO:0002520 | 195 | 0.310 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.306 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.305 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.305 | |
| cell cycle arrest | GO:0007050 | 71 | 0.300 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.300 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.295 | |
| tissue migration | GO:0090130 | 119 | 0.290 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.290 | |
| glial cell development | GO:0021782 | 7 | 0.285 | |
| regulation of response to wounding | GO:1903034 | 101 | 0.285 | |
| regulation of coagulation | GO:0050818 | 44 | 0.282 | |
| epithelium migration | GO:0090132 | 119 | 0.281 | |
| nucleosome organization | GO:0034728 | 66 | 0.280 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.279 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.279 | |
| vasculature development | GO:0001944 | 181 | 0.278 | |
| apoptotic nuclear changes | GO:0030262 | 13 | 0.272 | |
| ovulation cycle process | GO:0022602 | 9 | 0.272 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.272 | |
| skeletal system development | GO:0001501 | 79 | 0.270 | |
| regulation of hemostasis | GO:1900046 | 42 | 0.269 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 48 | 0.261 | |
| regulation of neuroblast proliferation | GO:1902692 | 3 | 0.258 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.254 | |
| neural crest cell differentiation | GO:0014033 | 5 | 0.250 | |
| endocrine pancreas development | GO:0031018 | 11 | 0.250 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.249 | |
| tube development | GO:0035295 | 125 | 0.249 | |
| cardiovascular system development | GO:0072358 | 262 | 0.246 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.243 | |
| ectodermal placode formation | GO:0060788 | 1 | 0.241 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.240 | |
| ovulation cycle | GO:0042698 | 9 | 0.236 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.233 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.231 | |
| dna catabolic process endonucleolytic | GO:0000737 | 37 | 0.227 | |
| taxis | GO:0042330 | 157 | 0.222 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.219 | |
| cellular component disassembly | GO:0022411 | 92 | 0.218 | |
| alcohol metabolic process | GO:0006066 | 114 | 0.216 | |
| regulation of wound healing | GO:0061041 | 56 | 0.216 | |
| positive regulation of intracellular estrogen receptor signaling pathway | GO:0033148 | 5 | 0.213 | |
| dna catabolic process | GO:0006308 | 49 | 0.213 | |
| cell morphogenesis | GO:0000902 | 296 | 0.213 | |
| response to estradiol | GO:0032355 | 23 | 0.213 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.211 | |
| intracellular signal transduction involved in g1 dna damage checkpoint | GO:1902400 | 10 | 0.205 | |
| embryo development | GO:0009790 | 123 | 0.204 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.204 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.203 | |
| lung morphogenesis | GO:0060425 | 6 | 0.203 | |
| regulation of intracellular protein transport | GO:0033157 | 123 | 0.203 | |
| response to steroid hormone | GO:0048545 | 80 | 0.203 | |
| mitotic g1 dna damage checkpoint | GO:0031571 | 17 | 0.199 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.198 | |
| n terminal peptidyl lysine acetylation | GO:0018076 | 4 | 0.198 | |
| detection of stimulus | GO:0051606 | 85 | 0.196 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 94 | 0.196 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.195 | |
| positive regulation of chondrocyte differentiation | GO:0032332 | 4 | 0.195 | |
| cellular potassium ion transport | GO:0071804 | 60 | 0.194 | |
| single organism cellular localization | GO:1902580 | 332 | 0.193 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.190 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 60 | 0.188 | |
| morphogenesis of a branching structure | GO:0001763 | 21 | 0.188 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.187 | |
| positive regulation of reproductive process | GO:2000243 | 9 | 0.186 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.185 | |
| regulation of cell growth | GO:0001558 | 135 | 0.183 | |
| developmental pigmentation | GO:0048066 | 12 | 0.181 | |
| lymphocyte activation | GO:0046649 | 133 | 0.181 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.180 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.175 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 85 | 0.175 | |
| circulatory system development | GO:0072359 | 262 | 0.174 | |
| generation of neurons | GO:0048699 | 152 | 0.174 | |
| epithelial to mesenchymal transition | GO:0001837 | 48 | 0.174 | |
| detection of stimulus involved in sensory perception | GO:0050906 | 43 | 0.174 | |
| lipid metabolic process | GO:0006629 | 381 | 0.172 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.171 | |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 15 | 0.169 | |
| response to mechanical stimulus | GO:0009612 | 51 | 0.169 | |
| blood vessel endothelial cell migration | GO:0043534 | 42 | 0.168 | |
| response to peptide | GO:1901652 | 65 | 0.167 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 76 | 0.166 | |
| response to transforming growth factor beta | GO:0071559 | 94 | 0.166 | |
| positive regulation of n terminal peptidyl lysine acetylation | GO:2000761 | 1 | 0.166 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 14 | 0.165 | |
| cell projection organization | GO:0030030 | 252 | 0.163 | |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.163 | Human |
| mitotic cell cycle checkpoint | GO:0007093 | 68 | 0.161 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 24 | 0.160 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.159 | |
| ovarian follicle development | GO:0001541 | 5 | 0.159 | |
| dna damage response detection of dna damage | GO:0042769 | 3 | 0.158 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.158 | |
| amine metabolic process | GO:0009308 | 44 | 0.156 | |
| pigmentation | GO:0043473 | 22 | 0.156 | |
| palate development | GO:0060021 | 13 | 0.156 | |
| response to hormone | GO:0009725 | 175 | 0.153 | |
| ossification | GO:0001503 | 121 | 0.151 | |
| skeletal system morphogenesis | GO:0048705 | 24 | 0.150 | |
| negative regulation of leukocyte activation | GO:0002695 | 26 | 0.148 | |
| execution phase of apoptosis | GO:0097194 | 32 | 0.147 | |
| regulation of protein stability | GO:0031647 | 87 | 0.146 | |
| mononuclear cell proliferation | GO:0032943 | 71 | 0.145 | |
| chondrocyte differentiation involved in endochondral bone morphogenesis | GO:0003413 | 1 | 0.143 | |
| cellular response to lipid | GO:0071396 | 127 | 0.143 | |
| negative regulation of cell development | GO:0010721 | 48 | 0.143 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 6 | 0.142 | Mouse |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.141 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.141 | |
| lens morphogenesis in camera type eye | GO:0002089 | 2 | 0.140 | |
| neurogenesis | GO:0022008 | 169 | 0.139 | |
| dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest | GO:0006977 | 9 | 0.139 | |
| tissue regeneration | GO:0042246 | 3 | 0.138 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.137 | |
| regulation of translation | GO:0006417 | 89 | 0.137 | |
| cell cell signaling | GO:0007267 | 155 | 0.136 | |
| connective tissue development | GO:0061448 | 39 | 0.135 | |
| heart development | GO:0007507 | 95 | 0.132 | |
| prostate gland development | GO:0030850 | 3 | 0.130 | |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.129 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.126 | |
| pituitary gland development | GO:0021983 | 2 | 0.123 | |
| skeletal muscle tissue development | GO:0007519 | 24 | 0.121 | |
| stem cell maintenance | GO:0019827 | 19 | 0.120 | |
| protein localization to organelle | GO:0033365 | 280 | 0.120 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.119 | |
| cellular response to peptide | GO:1901653 | 59 | 0.118 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 76 | 0.115 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.114 | |
| endothelial cell development | GO:0001885 | 18 | 0.114 | |
| reproductive process | GO:0022414 | 106 | 0.114 | |
| multi organism cellular process | GO:0044764 | 156 | 0.113 | Human |
| male gonad development | GO:0008584 | 23 | 0.113 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.112 | Human |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.112 | |
| hair cycle process | GO:0022405 | 12 | 0.111 | |
| cerebral cortex development | GO:0021987 | 10 | 0.111 | |
| ectodermal placode development | GO:0071696 | 1 | 0.110 | |
| mitotic g1 s transition checkpoint | GO:0044819 | 17 | 0.110 | |
| cell fate specification | GO:0001708 | 8 | 0.109 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.109 | |
| digestive tract development | GO:0048565 | 75 | 0.109 | |
| response to alcohol | GO:0097305 | 64 | 0.108 | |
| regulation of mononuclear cell proliferation | GO:0032944 | 65 | 0.105 | |
| cellular response to acid chemical | GO:0071229 | 44 | 0.104 | |
| epithelial cell development | GO:0002064 | 34 | 0.103 | |
| dna conformation change | GO:0071103 | 113 | 0.103 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 19 | 0.101 | |
| positive regulation of cell migration | GO:0030335 | 172 | 0.101 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.101 | |
| dna damage checkpoint | GO:0000077 | 68 | 0.099 | |
| lymphocyte proliferation | GO:0046651 | 70 | 0.099 | |
| regulation of endosome size | GO:0051036 | 3 | 0.098 | |
| cellular response to insulin stimulus | GO:0032869 | 41 | 0.098 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.098 | |
| regulation of ketone biosynthetic process | GO:0010566 | 7 | 0.097 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.096 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.096 | |
| negative regulation of cell cycle g1 s phase transition | GO:1902807 | 29 | 0.095 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 56 | 0.094 | |
| viral process | GO:0016032 | 146 | 0.094 | Human |
| cell projection morphogenesis | GO:0048858 | 129 | 0.092 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.090 | |
| organ morphogenesis | GO:0009887 | 147 | 0.089 | |
| development of primary male sexual characteristics | GO:0046546 | 23 | 0.089 | |
| regulation of protein localization | GO:0032880 | 296 | 0.088 | |
| glial cell differentiation | GO:0010001 | 11 | 0.087 | |
| sex determination | GO:0007530 | 3 | 0.087 | |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.086 | |
| protein dna complex subunit organization | GO:0071824 | 80 | 0.086 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.086 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.086 | |
| intracellular protein transport | GO:0006886 | 270 | 0.085 | |
| signal transduction involved in mitotic dna integrity checkpoint | GO:1902403 | 13 | 0.084 | |
| steroid biosynthetic process | GO:0006694 | 46 | 0.084 | |
| regulation of n terminal peptidyl lysine acetylation | GO:2000759 | 1 | 0.083 | |
| regulation of lymphocyte proliferation | GO:0050670 | 64 | 0.083 | |
| mitotic dna integrity checkpoint | GO:0044774 | 30 | 0.082 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.082 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.082 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.082 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.081 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.081 | |
| ectodermal placode morphogenesis | GO:0071697 | 1 | 0.081 | |
| dolichol biosynthetic process | GO:0019408 | 1 | 0.081 | |
| sodium ion transport | GO:0006814 | 61 | 0.081 | |
| sensory perception | GO:0007600 | 103 | 0.081 | |
| post embryonic development | GO:0009791 | 2 | 0.081 | |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 29 | 0.080 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 5 | 0.080 | |
| neuroepithelial cell differentiation | GO:0060563 | 5 | 0.080 | |
| negative regulation of ossification | GO:0030279 | 21 | 0.080 | |
| signal transduction involved in mitotic g1 dna damage checkpoint | GO:0072431 | 10 | 0.079 | |
| negative regulation of protein ubiquitination | GO:0031397 | 35 | 0.078 | |
| apoptotic dna fragmentation | GO:0006309 | 6 | 0.078 | |
| insulin receptor signaling pathway | GO:0008286 | 23 | 0.078 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.078 | |
| response to cytokine | GO:0034097 | 232 | 0.078 | |
| cellular component disassembly involved in execution phase of apoptosis | GO:0006921 | 13 | 0.077 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.076 | Human |
| regulation of isoprenoid metabolic process | GO:0019747 | 1 | 0.076 | |
| cell growth | GO:0016049 | 160 | 0.075 | |
| central nervous system development | GO:0007417 | 123 | 0.075 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.074 | Mouse |
| response to peptide hormone | GO:0043434 | 61 | 0.073 | |
| endocytosis | GO:0006897 | 159 | 0.072 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.072 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.072 | |
| trna processing | GO:0008033 | 23 | 0.070 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.070 | |
| regulation of protein acetylation | GO:1901983 | 25 | 0.070 | |
| positive regulation of notch signaling pathway | GO:0045747 | 6 | 0.070 | |
| maintenance of location | GO:0051235 | 112 | 0.069 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.068 | |
| negative regulation of cytoplasmic transport | GO:1903650 | 46 | 0.068 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.068 | |
| positive regulation of translation | GO:0045727 | 35 | 0.068 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.067 | |
| positive regulation of ossification | GO:0045778 | 32 | 0.067 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.067 | |
| neuron development | GO:0048666 | 113 | 0.066 | |
| development of primary female sexual characteristics | GO:0046545 | 10 | 0.066 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.065 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.065 | Human |
| regulation of chondrocyte differentiation | GO:0032330 | 9 | 0.064 | |
| sensory perception of mechanical stimulus | GO:0050954 | 37 | 0.064 | |
| odontogenesis | GO:0042476 | 25 | 0.064 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.063 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.062 | Human |
| signal transduction involved in cell cycle checkpoint | GO:0072395 | 16 | 0.062 | |
| pigment cell differentiation | GO:0050931 | 11 | 0.062 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 13 | 0.061 | |
| skeletal muscle organ development | GO:0060538 | 26 | 0.060 | |
| sodium ion transmembrane transport | GO:0035725 | 59 | 0.060 | |
| biological phase | GO:0044848 | 5 | 0.060 | |
| eye development | GO:0001654 | 42 | 0.060 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.060 | |
| leukocyte proliferation | GO:0070661 | 74 | 0.060 | |
| chemotaxis | GO:0006935 | 157 | 0.059 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 156 | 0.059 | Human |
| reproductive structure development | GO:0048608 | 55 | 0.059 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.059 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 116 | 0.059 | |
| inorganic ion transmembrane transport | GO:0098660 | 231 | 0.059 | |
| regulation of lymphocyte activation | GO:0051249 | 103 | 0.058 | |
| protein autoubiquitination | GO:0051865 | 37 | 0.058 | |
| response to insulin | GO:0032868 | 45 | 0.057 | |
| regulation of growth | GO:0040008 | 165 | 0.057 | |
| endodermal cell fate commitment | GO:0001711 | 4 | 0.057 | |
| response to interleukin 1 | GO:0070555 | 47 | 0.057 | |
| molting cycle process | GO:0022404 | 12 | 0.057 | |
| female sex differentiation | GO:0046660 | 12 | 0.056 | |
| negative regulation of intracellular transport | GO:0032387 | 60 | 0.056 | |
| cation transmembrane transport | GO:0098655 | 238 | 0.056 | |
| regulation of cell development | GO:0060284 | 161 | 0.055 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.055 | |
| muscle structure development | GO:0061061 | 98 | 0.055 | |
| endothelial cell differentiation | GO:0045446 | 26 | 0.053 | |
| actin filament based process | GO:0030029 | 224 | 0.053 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.053 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.052 | Mouse |
| positive regulation of transport | GO:0051050 | 336 | 0.052 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.052 | |
| protein catabolic process | GO:0030163 | 325 | 0.052 | |
| dna packaging | GO:0006323 | 77 | 0.052 | |
| fatty acid metabolic process | GO:0006631 | 115 | 0.052 | |
| regulation of protein ubiquitination | GO:0031396 | 95 | 0.051 | |
| cofactor metabolic process | GO:0051186 | 87 | 0.050 | |
| receptor internalization | GO:0031623 | 43 | 0.050 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.049 | |
| regulation of anatomical structure size | GO:0090066 | 101 | 0.049 | |
| mitotic dna damage checkpoint | GO:0044773 | 28 | 0.048 | |
| camera type eye development | GO:0043010 | 25 | 0.048 | |
| inorganic cation transmembrane transport | GO:0098662 | 194 | 0.048 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.048 | |
| gonad development | GO:0008406 | 34 | 0.048 | |
| cartilage development | GO:0051216 | 31 | 0.047 | |
| regulation of actin filament based process | GO:0032970 | 141 | 0.047 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.047 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.047 | |
| positive regulation of neuroblast proliferation | GO:0002052 | 2 | 0.047 | |
| mesenchymal stem cell differentiation | GO:0072497 | 8 | 0.047 | |
| cell cycle g1 s phase transition | GO:0044843 | 80 | 0.046 | |
| negative regulation of nucleocytoplasmic transport | GO:0046823 | 37 | 0.046 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 156 | 0.046 | |
| pigment biosynthetic process | GO:0046148 | 10 | 0.045 | |
| forebrain development | GO:0030900 | 26 | 0.045 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.045 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.045 | |
| developmental induction | GO:0031128 | 5 | 0.045 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.045 | |
| negative regulation of growth | GO:0045926 | 97 | 0.045 | |
| reproductive system development | GO:0061458 | 56 | 0.044 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.044 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.044 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.044 | |
| gland development | GO:0048732 | 48 | 0.044 | |
| rna processing | GO:0006396 | 255 | 0.043 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.043 | |
| cell activation | GO:0001775 | 213 | 0.043 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.043 | |
| ear morphogenesis | GO:0042471 | 7 | 0.042 | |
| growth | GO:0040007 | 202 | 0.042 | Mouse |
| odontogenesis of dentin containing tooth | GO:0042475 | 10 | 0.042 | |
| positive regulation of lipid metabolic process | GO:0045834 | 50 | 0.042 | |
| peptidyl lysine modification | GO:0018205 | 144 | 0.042 | |
| chromatin remodeling | GO:0006338 | 55 | 0.042 | |
| nuclear export | GO:0051168 | 69 | 0.042 | |
| mitochondrion organization | GO:0007005 | 156 | 0.041 | |
| hindbrain development | GO:0030902 | 3 | 0.041 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 44 | 0.041 | |
| endosomal transport | GO:0016197 | 129 | 0.040 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 34 | 0.040 | Mouse |
| hair cycle | GO:0042633 | 28 | 0.040 | |
| nephron development | GO:0072006 | 30 | 0.040 | |
| regulation of transporter activity | GO:0032409 | 82 | 0.039 | |
| regulation of protein export from nucleus | GO:0046825 | 15 | 0.039 | |
| regulation of cell activation | GO:0050865 | 125 | 0.039 | |
| regulation of lipid biosynthetic process | GO:0046890 | 47 | 0.039 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.039 | |
| regulation of potassium ion transmembrane transporter activity | GO:1901016 | 16 | 0.039 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.039 | |
| mapk cascade | GO:0000165 | 288 | 0.039 | Human |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.039 | |
| endosome transport via multivesicular body sorting pathway | GO:0032509 | 3 | 0.038 | |
